# K132281: ReVive PV (Peripheral Vasculature) Thrombectomy Device

- Pathway: 510(k) (Special)
- Applicant: Codman & Shurtleff, Inc.
- Decided: Aug 30, 2013 after 38 days
- Product code: QEW (Peripheral Mechanical Thrombectomy With Aspiration)
- Device class: 2
- Regulation: 21 CFR 870.5150
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K832023 (1983). 16 ancestors in all.
6 later devices descend from it; 2 cite it directly.
3 of 23 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K092623: F.a.S.T. System Sed and CXD, Genesis Medical Interventional, Inc. (2009) Summary page 5.

## Most influential descendants
- K221204: Excipio SV Thrombectomy Device (2022), 2 descendants of its own
- K201085: NeVa PV Thrombectomy Device (2021), 2 descendants of its own
- K223897: Excipio LV Thrombectomy Device (2023), 1 descendant of its own
- K254211: pVasc Net Mechanical Thrombectomy Device (2026), 0 descendants of its own
- K253407: NeVa PV Thrombectomy Device (2025), 0 descendants of its own

## Indications for use
The ReVive™ PV Thrombectomy Device is indicated for: The non-surgical removal of emboli and thrombi from peripheral blood vessels, The non-surgical removal of thrombi from synthetic grafts, Temporary use in peripheral vessel/graft occlusion, Use with aspiration and with the injection or infusion of contrast media and other fluids

Source page: https://510kreport.com/device/K132281
Methodology: https://510kreport.com/methodology